AITRICS VitalCare vs Healthplus.ai (2026)
Both predict complications in hospitalized adults from routine EHR data, at different moments. AITRICS VitalCare, from Seoul, predicts deterioration and sepsis on general wards from up to 19 routine inputs, publishing sensitivity, alarms per 100 patient days and lead time across two company led studies. Its 510(k) clears a rules based early warning dashboard, while the company claims clearance for its AI. Healthplus.ai, from Amsterdam, sells PERISCOPE, which gives each adult surgical patient a probability of postoperative bacterial infection at 7 and 30 days within an hour of surgery ending, shown in the EHR with the factors behind it. It is CE marked in Europe, has no FDA clearance, and publishes its results by patient subgroup. Choose VitalCare for ward deterioration; choose PERISCOPE to flag surgical patients at risk of infection before they leave recovery.
- The risk you are watching is deterioration or sepsis on general wards.
- You want sensitivity, alert burden and lead time published.
- Your wards measure patients intermittently rather than continuously.
- The risk you are watching is infection after surgery.
- Each prediction should show the factors behind it.
- Published results by patient subgroup matter to your committee.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AITRICS VitalCare and Healthplus.ai are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AITRICS VitalCare | Healthplus.ai |
|---|---|---|
| Primary category | Inpatient Deterioration & Risk Monitoring | Inpatient Deterioration & Risk Monitoring |
| Headquarters | Seoul, Republic of Korea | Amsterdam, Netherlands |
| Website | aitrics.com | healthplus.ai |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AITRICS is a Seoul medical AI company whose AITRICS-VC (VitalCare) predicts deterioration in hospitalized adults from routine electronic medical record data. It focuses on the general ward, where patients are measured intermittently rather than monitored continuously, so the models must work from sparse, irregular measurements.
Source: AI Health Index, September 2026
Healthplus.ai, based in Amsterdam, sells PERISCOPE, CE marked software that predicts which adult surgical patients will develop a postoperative bacterial infection. Within an hour of the end of surgery it gives each patient a probability of infection within 7 days and within 30 days, shown inside the electronic health record as a risk category with the factors that contributed most.
Source: AI Health Index, September 2026
Questions buyers ask
How do AITRICS VitalCare and Healthplus.ai work with the EHR?
For AITRICS VitalCare, the US 510(k) describes the software analyzing patient data sourced from the EHR, and the product page describes connecting to the hospital's internal network to collect EMR data.
With Healthplus.ai, the product page says PERISCOPE works directly inside Epic and is built to integrate with HiX, showing the risk category and contributing factors alongside patient data in the clinician's existing screen. The product reads pre and intraoperative data from the record and returns a prediction into it within an hour of the end of surgery, with no new data entry. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How are AITRICS VitalCare and Healthplus.ai priced and sold?
In AITRICS VitalCare's case, the product is sold to hospitals through an inquiry form, and in Korea it has entered the conditional new health technology assessment program, which bears on how it may be reimbursed there.
For Healthplus.ai, the company's own research argues local updating is needed for the models to perform at a new hospital, so the question bears on total cost. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How do AITRICS VitalCare and Healthplus.ai handle patient data?
With AITRICS VitalCare, the company holds ISO/IEC 27701 privacy management certification alongside ISO 27001 (LRQA, October 2025) and describes de-identification and encryption procedures across its data lifecycle. Its privacy policy, written under Korea's Personal Information Protection Act, covers product inquiries, customer support and recruitment, not the ward data AITRICS-VC processes in hospitals.
In Healthplus.ai's case, the published method retrains and recalibrates the models on each hospital's own historical record data before use, and the product draws only on data the record already holds, with no new data entry. Where that retraining runs is not stated, and the company offers both cloud and on premises installation. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Which settings and specialties do AITRICS VitalCare and Healthplus.ai cover?
For AITRICS VitalCare, the product covers inpatients 19 and older: adverse event and sepsis scores in general wards and a mortality score in the ICU under the Korean approval, while the US clearance covers only a rules-based general ward dashboard. The ward focus matters because ward patients are measured intermittently rather than continuously.
With Healthplus.ai, the outcome is postoperative bacterial infection broadly, including surgical site infection, pneumonia and urinary tract infection, rather than surgical site infection alone. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.
Both records were reviewed on this site in September 2026. Neither publishes a price. AITRICS's clearance covers a rules based dashboard rather than its AI, and PERISCOPE is CE marked in Europe with no FDA clearance, so neither is cleared for its AI in the United States.
Ask both which regulatory clearance applies in your country, and to which product.